SDTM

SDTM

  1. lut 28, 2025

What Does the 'SDTM’ Mean?

SDTM stands for Study Data Tabulation Model. It is a standard structure for submitting clinical trial data to regulatory authorities, developed by the Clinical Data Interchange Standards Consortium (CDISC).

SDTM provides a consistent framework for organizing and formatting clinical study data. This standardization facilitates data review, analysis, and sharing among different stakeholders in the clinical research process, including sponsors, contract research organizations, and regulatory agencies.

Why Is the 'SDTM’ Important in Clinical Research?

SDTM is crucial in clinical research as it ensures data consistency and comparability across studies. By providing a standardized format, it streamlines the regulatory submission process, reducing time and resources required for data preparation and review.

The implementation of SDTM enhances data quality and facilitates more efficient analysis. It also promotes data transparency and enables easier integration of data from multiple sources, supporting meta-analyses and the development of larger, more comprehensive datasets for research purposes.

Good Practices and Procedures

  1. Develop and maintain a comprehensive SDTM Implementation Guide (IG) tailored to your organization’s specific needs and study designs.
  2. Implement automated data validation checks to ensure SDTM compliance throughout the data collection and processing stages.
  3. Conduct regular training sessions for data managers and statisticians on SDTM updates and best practices.
  4. Establish a cross-functional SDTM review process involving data managers, biostatisticians, and medical writers to ensure data integrity and consistency.
  5. Create and maintain a library of SDTM-compliant controlled terminologies and codelists to ensure standardization across studies.

Related Terms

Resources

How ACT EU Is Forcing a Global Approach to Trial Timelines

Europe’s clinical trials market is entering a more practical phase in its approach to competitiveness. With the Clinical Trials Regulation…

Axcellant at ICNC Berlin: Following the Future of Nuclear Cardiology – and helping bring it to clinical reality

The Axcellant team recently attended the International Conference on Nuclear Cardiology (ICNC) in Berlin – one of the most important…

Axcellant Establishes Advisory Board to Strengthen Clinical and Strategic Leadership

Axcellant is pleased to announce the formation of its Advisory Board - a group of distinguished experts in clinical science,…